<DOC>
	<DOC>NCT00443677</DOC>
	<brief_summary>The purpose of this study is to compare the toxicities of the COPPEBVCAD vs BEACOPP vs ABVD regimens.</brief_summary>
	<brief_title>Treatment of Advanced Hodgkin's Disease (Stages IIB-III-IV)</brief_title>
	<detailed_description />
	<mesh_term>Hodgkin Disease</mesh_term>
	<criteria>Histologically confirmed diagnosis of Hodgkin disease Clinical stage IIB, III, IV No prior treatment for Hodgkin disease or other malignancy Age 1865 year Good cardiac, pulmunar, renal and hepatic function Performance status 03 (Karnofsky 100 40) Written Informed Consent HIV positivity Large cell, anaplastic, CD30+ lymphoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2009</verification_date>
</DOC>